Trial no.:
|
PACTR202102480485588 |
Date of Approval:
|
03/02/2021 |
Trial Status:
|
Registered in accordance with WHO and ICMJE standards |
|
TRIAL DESCRIPTION |
Public title
|
Meperdine Versus Dexmedetomidine as Adjuvants to Lignocaine in Intravenous Regional Anesthesia for below Elbow Orthopaedic Surgeries |
Official scientific title |
Meperdine Versus Dexmedetomidine as Adjuvants to Lignocaine in Intravenous Regional Anesthesia for below Elbow Orthopaedic Surgeries |
Brief summary describing the background
and objectives of the trial
|
Intravenous regional anesthesia (IVRA) is a safe and reliable method to provide anesthesia for below elbow surgeries.Main disadvantages are tourniquet pain and absence of postoperative analgesia.Many adjuvants have been added to lidocaine to overcome these problems.We designed this study to compare between pethidine and dexmedetomidine when added to lidocaine in IVRA. |
Type of trial |
RCT |
Acronym (If the trial has an acronym then please provide) |
|
Disease(s) or condition(s) being studied |
Anaesthesia |
Sub-Disease(s) or condition(s) being studied |
|
Purpose of the trial |
Treatment: Drugs |
Anticipated trial start date |
01/03/2021 |
Actual trial start date |
|
Anticipated date of last follow up |
31/10/2021 |
Actual Last follow-up date |
|
Anticipated target sample size (number of participants) |
105 |
Actual target sample size (number of participants) |
|
Recruitment status |
Not yet recruiting |
Publication URL |
|
|